Home › Stock analysis › DMII
Drugs Made In America Acquisition II (DMII) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
What changed since yesterday
- Closed at $10.18, -0.10% vs the prior close of $10.19.
- Volume 1.04M shares, 10.1x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
DMII ends flat (-0.1%) to $10.18 on 11.7x normal volume. Closed at $10.18, -0.10% vs the prior close of $10.19. Day range $10.18–$10.19, opened at $10.19.
Last close$10.18-0.10%
Day range10.18–10.19
Open10.19
Volume1.04M
52-week range9.86–10.33
Avg volume (20d)185.46K
DMII daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — DMII ends flat (-0.1%) to $10.18 on 11.7x normal volume
- Closed at $10.18, -0.10% vs the prior close of $10.19. Day range $10.18–$10.19, opened at $10.19.
- Volume was 1.04M shares, 11.7x its 50-day average of 88.96K — unusually heavy trading.
- Price is +0.2% vs its 50-day average ($10.16) and +1.3% vs its 200-day average ($10.05).
- 52-week range $9.86–$10.33; today's close sits at 68% of that range, 1.5% below the 52-week high.
- That makes 7 straight losses.
Oct 15, 2026 — DMII ends flat (+0.0%) to $10.19, 6 down days in a row
- Closed at $10.19, +0.00% vs the prior close of $10.19. Day range $10.18–$10.19, opened at $10.19.
- Volume was 121.80K shares, 1.4x its 50-day average of 86.53K.
- Price is +0.3% vs its 50-day average ($10.16) and +1.4% vs its 200-day average ($10.05).
- 52-week range $9.86–$10.33; today's close sits at 70% of that range, 1.4% below the 52-week high.
- That makes 6 straight losses.
Oct 14, 2026 — DMII ends flat (+0.0%) to $10.19, 5 down days in a row
- Closed at $10.19, +0.00% vs the prior close of $10.19. Day range $10.19–$10.19, opened at $10.19.
- Volume was 400 shares, 0.0x its 50-day average of 86.53K — lighter than usual.
- Price is +0.3% vs its 50-day average ($10.16) and +1.4% vs its 200-day average ($10.05).
- 52-week range $9.86–$10.33; today's close sits at 70% of that range, 1.4% below the 52-week high.
- That makes 5 straight losses.
Oct 13, 2026 — DMII ends flat (+0.0%) to $10.19 on 4.7x normal volume
- Closed at $10.19, +0.00% vs the prior close of $10.19. Day range $10.19–$10.19, opened at $10.19.
- Volume was 374.50K shares, 4.7x its 50-day average of 79.04K — unusually heavy trading.
- Price is +0.3% vs its 50-day average ($10.15) and +1.4% vs its 200-day average ($10.05).
- 52-week range $9.86–$10.33; today's close sits at 70% of that range, 1.4% below the 52-week high.
- That makes 4 straight losses.
Oct 12, 2026 — DMII ends flat (+0.0%) to $10.19 on 13.2x normal volume
- Closed at $10.19, +0.00% vs the prior close of $10.19. Day range $10.19–$10.20, opened at $10.19.
- Volume was 859.40K shares, 13.2x its 50-day average of 64.95K — unusually heavy trading.
- Price is +0.4% vs its 50-day average ($10.15) and +1.4% vs its 200-day average ($10.05).
- 52-week range $9.86–$10.33; today's close sits at 70% of that range, 1.4% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — DMII ends flat (+0.0%) to $10.19 on 11.3x normal volume
- Closed at $10.19, +0.00% vs the prior close of $10.19. Day range $10.19–$10.19, opened at $10.19.
- Volume was 600.20K shares, 11.3x its 50-day average of 52.94K — unusually heavy trading.
- Price is +0.4% vs its 50-day average ($10.15) and +1.4% vs its 200-day average ($10.05).
- 52-week range $9.86–$10.33; today's close sits at 70% of that range, 1.4% below the 52-week high.
Oct 8, 2026 — DMII ends flat (+0.0%) to $10.19 on 5.1x normal volume
- Closed at $10.19, +0.00% vs the prior close of $10.19. Day range $10.19–$10.19, opened at $10.19.
- Volume was 250.20K shares, 5.1x its 50-day average of 49.05K — unusually heavy trading.
- Price is +0.4% vs its 50-day average ($10.15) and +1.4% vs its 200-day average ($10.04).
- 52-week range $9.86–$10.33; today's close sits at 70% of that range, 1.4% below the 52-week high.
Oct 7, 2026 — DMII ends flat (+0.0%) to $10.19 on 2.3x normal volume
- Closed at $10.19, +0.05% vs the prior close of $10.19. Day range $10.18–$10.20, opened at $10.20.
- Volume was 119.00K shares, 2.3x its 50-day average of 50.72K — unusually heavy trading.
- Price is +0.4% vs its 50-day average ($10.15) and +1.5% vs its 200-day average ($10.04).
- 52-week range $9.86–$10.33; today's close sits at 70% of that range, 1.4% below the 52-week high.
Oct 6, 2026 — DMII ends flat (-0.0%) to $10.19 on 2.1x normal volume
- Closed at $10.19, -0.05% vs the prior close of $10.19. Day range $10.18–$10.20, opened at $10.20.
- Volume was 103.30K shares, 2.1x its 50-day average of 50.26K — unusually heavy trading.
- Price is +0.4% vs its 50-day average ($10.15) and +1.4% vs its 200-day average ($10.04).
- 52-week range $9.86–$10.33; today's close sits at 69% of that range, 1.4% below the 52-week high.
- That makes 3 straight losses.
Oct 5, 2026 — DMII ends flat (+0.0%) to $10.19
- Closed at $10.19, +0.00% vs the prior close of $10.19. Day range $10.18–$10.19, opened at $10.19.
- Volume was 2.20K shares, 0.0x its 50-day average of 50.22K — lighter than usual.
- Price is +0.4% vs its 50-day average ($10.15) and +1.5% vs its 200-day average ($10.04).
- 52-week range $9.86–$10.33; today's close sits at 70% of that range, 1.4% below the 52-week high.
Oct 2, 2026 — DMII ends flat (+0.0%) to $10.19
- Closed at $10.19, +0.00% vs the prior close of $10.19. Day range $10.19–$10.19, opened at $10.19.
- Volume was 17.70K shares, 0.3x its 50-day average of 50.81K — lighter than usual.
- Price is +0.5% vs its 50-day average ($10.14) and +1.5% vs its 200-day average ($10.04).
- 52-week range $9.86–$10.33; today's close sits at 70% of that range, 1.4% below the 52-week high.
DMII latest news & SEC filings
Every SEC filing by or about DMII in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: $4.40M (prior year -$38.07K) (swung to profit vs Jun 30, 2025)
Things to know before you trade DMII
- How much it moves: over the last 20 sessions the average daily move was 0.04% (largest 0.1%). That is a relatively calm stock.
- Liquidity: about 185.46K shares (≈$1.89M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $10.18 vs a range of $9.86–$10.33 (68% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 8 open-market buys, 8 sales; latest: Made In America Acquisition Ii Llc Drugs bought 700,000 shares on Sep 26, 2025.
- Latest filings: 10-Q Aug 14, 2026; 10-Q May 14, 2026; 8-K Apr 28, 2026.
- Listing: Nasdaq · industry: Blank Checks.
DMII market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 10.19 | 10.19 | 10.18 | 10.18 | 1.04M |
| Oct 15, 2026 | 10.19 | 10.19 | 10.18 | 10.19 | 121.80K |
| Oct 14, 2026 | 10.19 | 10.19 | 10.19 | 10.19 | 400 |
| Oct 13, 2026 | 10.19 | 10.19 | 10.19 | 10.19 | 374.50K |
| Oct 12, 2026 | 10.19 | 10.20 | 10.19 | 10.19 | 859.40K |
| Oct 9, 2026 | 10.19 | 10.19 | 10.19 | 10.19 | 600.20K |
| Oct 8, 2026 | 10.19 | 10.19 | 10.19 | 10.19 | 250.20K |
| Oct 7, 2026 | 10.20 | 10.20 | 10.18 | 10.19 | 119.00K |
| Oct 6, 2026 | 10.20 | 10.20 | 10.18 | 10.19 | 103.30K |
| Oct 5, 2026 | 10.19 | 10.19 | 10.18 | 10.19 | 2.20K |
| Oct 2, 2026 | 10.19 | 10.19 | 10.19 | 10.19 | 17.70K |
| Oct 1, 2026 | 10.18 | 10.19 | 10.18 | 10.19 | 132.50K |
| Sep 30, 2026 | 10.18 | 10.18 | 10.18 | 10.18 | 1.20K |
| Sep 29, 2026 | 10.17 | 10.18 | 10.17 | 10.18 | 16.90K |
| Sep 28, 2026 | 10.16 | 10.16 | 10.16 | 10.16 | 0 |
| Sep 25, 2026 | 10.15 | 10.16 | 10.15 | 10.16 | 26.40K |
| Sep 24, 2026 | 10.15 | 10.15 | 10.15 | 10.15 | 200 |
| Sep 23, 2026 | 10.16 | 10.16 | 10.16 | 10.16 | 2.20K |
| Sep 22, 2026 | 10.15 | 10.15 | 10.15 | 10.15 | 200 |
| Sep 21, 2026 | 10.33 | 10.33 | 10.15 | 10.15 | 37.90K |
About Drugs Made In America Acquisition II
Drugs Made In America Acquisition II (DMII) is listed on the Nasdaq and classified by the SEC under “Blank Checks”. Its business address is in NEW YORK, NY. Fiscal year ends December 31. SEC CIK 2040475.
DMII board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Catherine Do | Director | Oct 17, 2025 |
| Sridhar G. Prasad | Director | Oct 1, 2025 |
| Myron W. Shulgan | Director | Oct 2, 2025 |
| Lynn Stockwell | CEO and Exe. Chair of Board | Oct 1, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Lynn Stockwell | CEO and Exe. Chair of Board | Oct 1, 2025 |
| Glenn C. Worman | CFO | Oct 1, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 26, 2025 | Made In America Acquisition Ii Llc Drugs | Buy | 700,000 | — |
| Sep 26, 2025 | Made In America Acquisition Ii Llc Drugs | Sale | 7,966,667 | — |
| Sep 26, 2025 | Made In America Acquisition Ii Llc Drugs | Buy | 700,000 | — |
| Sep 26, 2025 | Made In America Acquisition Ii Llc Drugs | Sale | 7,966,667 | — |
| Sep 26, 2025 | Made In America Acquisition Ii Llc Drugs | Buy | 700,000 | — |
| Sep 26, 2025 | Made In America Acquisition Ii Llc Drugs | Sale | 7,966,667 | — |
| Sep 26, 2025 | Made In America Acquisition Ii Llc Drugs | Buy | 700,000 | — |
| Sep 26, 2025 | Made In America Acquisition Ii Llc Drugs | Sale | 7,966,667 | — |
| Sep 26, 2025 | Lynn Stockwell | Buy | 700,000 | — |
| Sep 26, 2025 | Lynn Stockwell | Sale | 7,966,667 | — |
| Sep 26, 2025 | Lynn Stockwell | Buy | 700,000 | — |
| Sep 26, 2025 | Lynn Stockwell | Sale | 7,966,667 | — |
| Sep 26, 2025 | Lynn Stockwell | Buy | 700,000 | — |
| Sep 26, 2025 | Lynn Stockwell | Sale | 7,966,667 | — |
| Sep 26, 2025 | Lynn Stockwell | Buy | 700,000 | — |
DMII financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $4.19M | — | $-1.02M |
Latest balance sheet: total assets $514.10M, total liabilities $18.14M, cash $174.97K (as of Jun 30, 2026).
DMII earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Blank Checks
Southport Acquisition Corp. II (PORT-UN)Bold Eagle Acquisition (BEAG)Innventure (INV)Live Oak Acquisition Corp. VI (LOVIU)Pine Tree Acquisition (PAXGU)Frazier Life Sciences Acquisition Corp. II (FLSC)Archimedes Tech SPAC Partners II (ATII)Bluerock Acquisition Corp. II (BRRKU)EQV Ventures Acquisition Corp. II (EVAC)Pyrophyte Acquisition Corp. II (PAII)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on DMII
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.